UPA Labs Retatrutide 30mg Pen (Retlira)

Weight Management • Appetite Control • Metabolic Support

RETLIRA: Triple-Action Peptide Therapy for Weight Loss

Overview: RETLIRA is a cutting-edge weight loss therapy featuring 30mg of Retatrutide, designed to target multiple metabolic pathways through a once-weekly injection. Its unique formulation sets it apart from traditional GLP-1 agonists, making it particularly beneficial for those who have not achieved desired results with other therapies like Semaglutide or Tirzepatide.

Key Mechanisms of Action:

• GLP-1 Receptors: Reduces appetite and stabilizes blood sugar levels.
• GIP Receptors: Enhances insulin sensitivity, aiding in glucose control.
• Glucagon Receptors: Promotes fat burning and boosts metabolism.

Benefits:

• Clinically Backed: Proven effectiveness for fat loss and glucose management.
• Convenient Administration: Delivered via a pre-filled pen, allowing easy self-injection.
• Long-term Support: Aids in appetite regulation, visceral fat loss, and improvement in insulin levels.
• Advanced Protocols: Utilized in state-of-the-art obesity management programs.

Disclaimer

This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPRA) for human or animal use.

Not for human consumption or medical use. Products sold on this website are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, the customer confirms they are qualified to handle and use this product in accordance with applicable laws and regulations.